tiprankstipranks
United Therapeutics (UTHR)
NASDAQ:UTHR
US Market
UTHR
United Therapeutics
RESEARCH TOOLSreports
Want to see UTHR full AI Analyst Report?

United Therapeutics (UTHR) Income Statement

713 Followers

United Therapeutics Income Statement

Last quarter (Q4 2025), United Therapeutics's total revenue was $790.20M, an increase of 7.38% from the same quarter last year. In Q4, United Therapeutics's net income was $364.30M. See United Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 3.18B$ 2.88B$ 2.33B$ 1.94B$ 1.69B
Gross Profit
$ 2.80B$ 2.57B$ 2.07B$ 1.79B$ 1.56B
Operating Expenses
$ 1.31B$ 1.19B$ 885.10M$ 809.90M$ 1.01B
Depreciation and Amortization
$ 85.60M$ 72.50M$ 53.20M$ 51.30M$ 49.90M
EBITDA
$ 1.82B$ 1.65B$ 1.39B$ 1.04B$ 736.80M
Operating Income
$ 1.49B$ 1.38B$ 1.18B$ 979.70M$ 555.90M
Other Income/Expenses
$ 221.40M$ 162.00M$ 89.40M$ -29.10M$ 38.00M
Pretax Income
$ 1.71B$ 1.54B$ 1.27B$ 950.60M$ 593.90M
Net Income
$ 1.33B$ 1.20B$ 984.80M$ 727.30M$ 475.80M
Per Share Metrics
Basic EPS
$ 30.13$ 26.44$ 21.04$ 15.98$ 10.60
Diluted EPS
$ 27.86$ 24.64$ 19.81$ 15.00$ 10.06
Weighted Average Shares Outstanding
 44.30M 45.20M 46.80M 45.50M 44.90M
Weighted Average Shares Outstanding (Diluted)
 47.90M 48.50M 49.70M 48.50M 47.30M
Currency in USD

United Therapeutics Earnings and Revenue History